SQSTM1 and nasopharyngeal carcinoma: Functional assays revealed that genetic and pharmacological suppression of HAX-1 restored autophagic flux, reduced SQSTM1 accumulation, and sensitised NPC cells to cisplatin in vitro and in xenograft models [52].